Oriola-KD Corporation Recognizes EUR 74 Million Impairment Charge For Russian Pharmaceutical Wholesale Operating Segment

Published: Jun 05, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Oriola-KD Corporation recognizes an estimated EUR 74 million impairment charge for Russian pharmaceutical wholesale impacting the 2014 second quarter results. The impairment charge consists of goodwill EUR 67 million, intangible assets EUR 1 million and deferred tax assets EUR 6 million. After impairment no goodwill is allocated to the Russian wholesale business.

Help employers find you! Check out all the jobs and post your resume.

Back to news